United Therapeutics Corporation (UTHR)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	2,268,200	2,147,800	2,060,800	1,939,800	1,903,900	1,743,300	1,676,600	1,657,700	1,666,900	1,751,900	1,687,000	1,601,600	1,491,500	1,399,000	1,425,300	1,442,500	1,448,800	1,519,100	1,530,300	1,601,200
Total assets	US$ in thousands	7,167,000	7,023,600	6,681,300	6,346,000	6,044,500	5,781,600	5,543,300	5,359,800	5,169,100	5,048,900	4,844,900	4,641,000	4,615,000	4,411,200	4,219,400	4,025,900	3,913,400	3,999,600	3,898,900	3,726,700
Total asset turnover		0.32	0.31	0.31	0.31	0.31	0.30	0.30	0.31	0.32	0.35	0.35	0.35	0.32	0.32	0.34	0.36	0.37	0.38	0.39	0.43

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,268,200K ÷ $7,167,000K
= 0.32

United Therapeutics Corp's total asset turnover has been relatively stable over the past eight quarters, ranging between 0.31 and 0.33. This ratio indicates that for every dollar of total assets the company holds, it generates between $0.31 and $0.33 in revenue. A total asset turnover ratio of around 0.32 suggests that the company is efficient in utilizing its assets to generate sales.

Overall, the consistent total asset turnover indicates that United Therapeutics Corp has been maintaining a stable level of efficiency in generating revenue from its total asset base. It is important for the company to continue monitoring and managing this ratio to ensure that its assets are being effectively utilized to drive sales and profitability.